92 results on '"Frean M"'
Search Results
2. An Overview of the SKA Science Analysis Pipeline
3. Detecting Diffuse Sources in Astronomical Images
4. Dissecting magnetar variability with Bayesian hierarchical models
5. Software graphs and programmer awareness
6. P.68 Validation of a composite prognostic score for time to loss of ambulation in Duchenne muscular dystrophy
7. P.126 Genotype-unmatched controls are feasible for drug development in Duchenne muscular dystrophy (DMD)
8. PCR174 Characterizing Progressive Disease Burden amid Heterogeneity: Data Visualizations for Ambulatory Motor Function in Duchenne Muscular Dystrophy (DMD)
9. Cellular expression pattern of the glycine decarboxylase P protein in leaves of an intergeneric hybrid between the C3-C4 intermediate species Moricandia nitens and the C3 species Brassica napus
10. Predictive Modelling of The Dynamic Patterns of Thinking in Attention-Deficit/Hyperactivity Disorder: Diagnostic Accuracy of Spatiotemporal Fractal Measures
11. A Comparative Study of the Structure-Function Relationship of Cross Veins in Leaves of Digitaria eriantha and Zea mays
12. C₃ and C₄ Photosynthetic and Anatomical Forms of Alloteropsis semialata (R. Br.) Hitchcock. 2. A Comparative Investigation of Leaf Ultrastructure and Distribution of Chlorenchyma in the Two Forms
13. C₃ and C₄ Photosynthetic and Anatomical forms of Alloteropsis semialata (R. Br.) Hitchcock: I. Variability in Photosynthetic Characteristics, Water Utilization Efficiency and Leaf Anatomy
14. The Occurrence of Both C 3 and C 4 Photosynthetic Characteristics in a Single Zea mays Plant
15. An Overview of the SKA Science Analysis Pipeline
16. The occurrence of both C3 and C4 photosynthetic characteristics in a single Zea mays plant
17. An Assessment of Factors associated with high costs among Patients With Multiple Sclerosis (Ms) Receiving Disease-Modifying Drug (Dmd) Therapy
18. Trends In Anti-Epileptic Adjunctive Therapy Utilization And Costs From 2006-2011: An Analysis Of A Large Administrative Claims Database
19. Bayesian Multiple Person Tracking using Probability Hypothesis Density Smoothing
20. PND22 - An Assessment of Factors associated with high costs among Patients With Multiple Sclerosis (Ms) Receiving Disease-Modifying Drug (Dmd) Therapy
21. Functional Gradient Techniques for Combining Hypotheses
22. Boosting Algorithms as Gradient Descent
23. Modularity adaptation in cooperative coevolution of feedforward neural networks.
24. A memetic framework for cooperative coevolution of recurrent neural networks.
25. A novel distributed content replication and placement scheme for Wireless Mesh Networks.
26. A meta-heuristic paradigm for solving the forward kinematics of 6–6 general parallel manipulator.
27. PND18 - Trends In Anti-Epileptic Adjunctive Therapy Utilization And Costs From 2006-2011: An Analysis Of A Large Administrative Claims Database
28. C3 and C4 Photosynthetic and Anatomical Forms of Alloteropsis semialata (R.Br.) Hitchcock.
29. C3 and C4 Photosynthetic and Anatomical forms of Alloteropsis semialata (R.Br.) Hitchcock.
30. The occurrence of both C3 and C4 photosynthetic characteristics in a single Zea mays plant
31. The shattered gradients problem: If resnets are the answer, then what is the question?
32. Sporoderm morphogenesis in Euphorbia obesa and Croton gratissimus
33. Intraspecifíc variability in Alloteropsis semialata (R. Br.) Hitchc.
34. PND22 An Assessment of Factors associated with high costs among Patients With Multiple Sclerosis (Ms) Receiving Disease-Modifying Drug (Dmd) Therapy
35. PND18 Trends In Anti-Epileptic Adjunctive Therapy Utilization And Costs From 2006-2011: An Analysis Of A Large Administrative Claims Database
36. 881PCorrelations between disease-free survival (DFS) and overall survival (OS) in patients (pts) with renal cell carcinoma (RCC) at high risk for recurrence: Results from S-TRAC trial.
37. Score-mediated mutual consent and indirect reciprocity.
38. Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status.
39. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1.
40. Patients' Perceptions of Integrated Care Among Medicare Beneficiaries by Level of Need for Health Services.
41. Holds enable one-shot reciprocal exchange.
42. Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018.
43. Higher Medicare Expenditures Are Associated With Better Integrated Care as Perceived by Patients.
44. Differences in patient perceptions of integrated care among black, hispanic, and white Medicare beneficiaries.
45. Patient Experiences of Integrated Care in Medicare Accountable Care Organizations and Medicare Advantage Versus Traditional Fee-for-Service.
46. Effective Leadership of Surgical Teams: A Mixed Methods Study of Surgeon Behaviors and Functions.
47. Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.
48. Medical Group Structural Integration May Not Ensure That Care Is Integrated, From The Patient's Perspective.
49. Premium subsidies, the mandate, and Medicaid expansion: Coverage effects of the Affordable Care Act.
50. Disentangling the ACA's Coverage Effects - Lessons for Policymakers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.